BPC (Bulk Pharmaceutical Chemical) with Nephrotoxin

Indications for use drugs: Adults in the complex therapy: HIV infection (stage 2A-3B); neyroinfektsiy: serous meningitis and encephalitis, Lyme disease, VHA, unaged HCV, VHD; herpeca and CMV infection, secondary immunodeficiency associated unaged G and Mts bacterial and fungal infections, chlamydial infections, rheumatic and systemic connective tissue diseases (RA, systemic lupus erythematosus), degenerative joint diseases destructional: osteoarthrosis deformans and others.; children after 4 years in komplesniy therapy: here VHB, VHC, VHD, VHGP; herpetic infection of HIV infection (stage 2A-ZB), influenza and SARS, combined therapy of intestinal diseases (ulcer disease, viral enteritis, etc.) as a means of immune surveillance for the prevention of carcinogenesis in high risk groups (radiation contamination the contaminated areas, etc.). Quart (the rate of 3 g, 20 tab.), with HR. appointment (the rate 6.0 g, 40 tab.) unaged course of repetition rate in 10-14 days 2 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days of treatment and further supporting the scheme once in five days prohyahom two and a half months while maintaining and replicating tsytolitychnoyi the pathologic process ( rate of 15 g, 100 tab.), with HR. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days, with HIV infection (stage 1A-ZB) preparation as a reference for the scheme in Table 4. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 day (course 3 - 6 g, unaged 20-40.), with frequently recurrent form of unaged disease start treatment early deterioration, at neuroinfections take a basic course with 4 tab. an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. bacterial infections (neuroinfections, chlamydia, bronchitis, pneumonia, postoperative complications, urogenital infections, peptic ulcer disease) as a component of immunotherapy; shows efficacy in rheumatic and systemic diseases of connective tissue through Total Leucocyte Count of autoimmune responses and anti-inflammatory and anesthetic action, has antykantserohennu and antimetastatic actions through Heart Rate of host-defense system preventing formation of tumors. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table.